Fact CheckerSign in

NCT06495684Recruiting

Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)

Source: ClinicalTrials.gov · Last updated 11 Sept 2026

Brief summary (registry, in English)

The purpose of this clinical trial is to investigate the effects of multiple sessions of transcranial direct current stimulation (tDCS) delivered while participants complete tasks that target social learning with high functioning adults with ASD and/or high traits of ASD. The main question it aims to answer is: What are the effects of multiple sessions of active compared to sham tDCS, with tDCS simultaneously paired with social learning tasks, from employing a within-subject, cross-over randomized controlled trial design? Participants will: * Complete a randomly assigned block of 5 sessions of active and a block of 5 sessions of sham tDCS, with a four-week break occurring between the two blocks. * Complete social learning tasks simultaneously during receipt of tDCS at each session (whether receiving active or sham tDCS). * Complete behavioral, physiological, and electrophysiological testing before and after each block of active or sham tDCS. * Complete a social validity questionnaire after completion of the study.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
25 Jun 2024
Start date
12 Mar 2024
Primary completion date
30 Oct 2026
Lead sponsor
University of New Mexico
Diseases
Autism
NCT number
NCT06495684

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 12 Mar 2024 to the primary completion date, 30 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • No surgically implanted metal above the neck (example: metal pins or plates, cochlear implants, aneurysm clips, brain electrodes)

Other illness

  • No immediate biological family members with a history of epilepsy or seizure disorder
  • No major medical needs (e.g., neurological disorders such as a seizure disorder; long-term illness)
  • No history of neurological disorders such as stroke, multiple sclerosis, bipolar disorder, encephalitis, epilepsy, seizure disorder, or amyotrophic lateral sclerosis

Other

  • No known loss of consciousness for \> 5 minutes
  • No hospitalization for depression, anxiety, or substance abuse in the past 12 months
  • No individuals who are currently pregnant
  • No pacemakers

Who the study is looking for

  • Age 18-35 years
  • Proficient in English
  • Classification of autism or autism spectrum disorder on Autism Diagnostic Observation Scale, 2nd Edition (ADOS-2) or score of \>= 17 on Autism Quotient (AQ)
  • Good or corrected vision and hearing
  • Right-handed based on the Edinburgh Handedness Inventory
  • Score of \>= 85 on Shipley-2

Age in the registry: 18 years to 35 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of New Mexico
Coordinator of this site? Confirm its status
AlbuquerqueUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.